REICIN ALISE 4
4 · Tectonic Therapeutic, Inc. · Filed Feb 12, 2026
Research Summary
AI-generated summary of this filing
Tectonic Therapeutic (TECX) CEO Alise Reicin Buys Stock
What Happened
Alise Reicin, CEO of Tectonic Therapeutic (TECX), reported a purchase of 2,500 shares on February 11, 2026. The shares were acquired at a weighted average price of $21.10 per share for a total cost of approximately $52,750. The Form 4 marks the transaction type as "P" (purchase), indicating an open-market or private purchase.
Key Details
- Transaction date: 2026-02-11 (reported on Form 4 filed 2026-02-12) — filing appears timely.
- Price: weighted average $21.10; individual trades ranged from $21.02 to $21.15 (footnote).
- Shares acquired: 2,500; total reported value ≈ $52,750.
- Shares held after transaction: not disclosed in the provided filing.
- Footnotes of note:
- F1: Price is a weighted average; the reporting person will provide a breakdown of the number of shares bought at each price upon request.
- F2: These shares are held by the Reicin-Boiarsky Family Trust; the CEO’s spouse is a co-trustee. The reporting person may be deemed to share voting/dispositive power but disclaims beneficial ownership except to the extent of any pecuniary interest.
Context
Purchases by company insiders are often viewed as a positive signal because they increase the insider’s stake, but they do not prove future stock performance. This filing documents a straightforward purchase (code P) rather than an option exercise, gift, or award. No late-filing flag was apparent given the transaction and filing dates.
Insider Transaction Report
- Purchase
Common Stock
[F1]2026-02-11$21.10/sh+2,500$52,750→ 237,547 total
- 124,530(indirect: By Trust)
Common Stock
[F2]
Footnotes (2)
- [F1]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $21.02 to $21.15, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
- [F2]These shares are held by the Reicin-Boiarsky Family Trust (the "Trust"). The Reporting Person's spouse is a co-trustee of the Trust. Accordingly, the Reporting Person may be deemed to have shared voting and dispositive power over the securities held by the Trust. The Reporting Person disclaims beneficial ownership of the shares held by the Trust except to the extent of her pecuniary interest therein, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.